Drug: DIFLUCAN Injury: Hepatocellular injury Quarter: 2016Q3
Total Records: 5 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 125216271 | DIFLUCAN | Hepatocellular injury | MERCK | 69.04 YR | F | 0 | 20160701 | CH |
| 125278041 | DIFLUCAN | Hepatocellular injury | NOVARTIS | 69.04 YR | F | 0 | 20160705 | CH |
| 125308391 | DIFLUCAN | Hepatocellular injury | PFIZER | 69.00 YR | F | 0 | 20160706 | CH |
| 125397461 | DIFLUCAN | Hepatocellular injury | TAKEDA | 69.00 YR | F | 0 | 20160708 | CH |
| 126550671 | DIFLUCAN | Hepatocellular injury | PFIZER | 73.00 YR | M | 60 KG | 20160816 | CN |
Total Records: 5 Number of Pages: 1